Until now, only a few studies have been carried out applying protein-loaded MSC-derived EVs in anti-cancer therapy, among which tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is representative [126]. This evidence concerns the gene TNFSF10 and cancer.